Brief: Vericel Q4 Net Income USD 13 Million
29/02/2024 12:55
Feb 29 (Reuters) - Vericel Q4 adjusted EBITDA USD 22.3 million. * Q4 gross margin 75% * outlook FY revenue USD 237-241 million
Recent news on Vericel
See all newsMedTech growth concerns likely to overshadow Q3 results, Leerink says
Vericel Corp reports results for the quarter ended June 30 - Earnings Summary
Vericel beats Q2 revenue estimates, boosts annual outlook
Brief: Vericel Q2 EPS USD 0.04
Vericel beats Q1 revenue on MACI, burn care growth, lifts 2026 sales outlook